Abbott Laboratories (ABT) Stock Overview
Explore Abbott Laboratories’s financial performance, market position, analyst ratings, and future outlook.
Abbott Laboratories (ABT)
Key Financials
Key Financials
Market Cap
165.6B
P/E Ratio
26.51
EPS (TTM)
$5.21
ROE
0.12%
ABT Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Abbott Laboratories (ABT) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 61.06, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $101.95.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 26.51 and a market capitalization of 165.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.